Get started
Author

Andrea Núñez Ortiz

Observed names: A NUÑEZ ORTIZ, A Nuñez Ortiz, A Núñez Ortiz, A. Ortiz, Andrea Nuñez Ortiz
OpenAlex ID: A5045680902
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 105
Long-Term Real-World Effectiveness and Safety of Ustekinumab in Crohn’s Disease Patients: The SUSTAIN Study
2022 · María Chaparro, Iria Baston-Rey, et al. · Inflammatory Bowel Diseases · 70
Efficacy and safety of tofacitinib in the treatment of ulcerative colitis: real-life experience in Andalusia
2022 · Alvaro Hernández Martínez, Pilar Navajas Hernández, et al. · Revista Española de Enfermedades Digestivas · 14
PDF
P744 Safety of live vaccines in children exposed to biological agents for inflammatory bowel disease (IBD) in utero or during breastfeeding
2023 · M Chaparro, M García Donday, et al. · Journal of Crohn s and Colitis · 11
PDF
Using Interpretable Machine Learning to Identify Baseline Predictive Factors of Remission and Drug Durability in Crohn’s Disease Patients on Ustekinumab
2022 · María Chaparro, Iria Baston-Rey, et al. · Journal of Clinical Medicine · 10
Impact of Epstein-Barr virus infection on inflammatory bowel disease (IBD) clinical outcomes
2021 · Andrea Núñez Ortiz, María Rojas Feria, et al. · Revista Española de Enfermedades Digestivas · 9
Perianal Crohn�s disease: clinical implications, prognosis and use of resources
2021 · Elia Rosa Martínez Sánchez, Ana Solá Fernández, et al. · Revista Española de Enfermedades Digestivas · 8
PDF
Anti-tumour necrosis factor discontinuation in inflammatory bowel disease patients in remission: study protocol of a prospective, multicentre, randomized clinical trial
2019 · María Chaparro, María G. Donday, et al. · Therapeutic Advances in Gastroenterology · 7
Hemosuccus pancreaticus secondary to pseudoaneurysm of the splenic artery
2017 · Mariano José Parada Blázquez, Andrea Núñez Ortiz · Revista Española de Enfermedades Digestivas · 6
Cell Phone-Induced Chondrodermatitis Nodularis Antihelicis
2015 · A. Ortiz, P. Martín, et al. · Actas Dermo-Sifiliográficas · 5
PDF
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
2022 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 4
Megacolon in inflammatory bowel disease: response to infliximab
2020 · Andrea Núñez Ortiz, Claudio Trigo Salado, et al. · Revista Española de Enfermedades Digestivas · 4
Topical mesalazine as a cause of Stevens-Johnson syndrome: a case report
2018 · Andrea Núñez Ortiz, Claudio Trigo Salado, et al. · Revista Española de Enfermedades Digestivas · 4
Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study of GETECCU
2025 · Esteban Fuentes-Valenzuela, Iria Bastón-Rey, et al. · Journal of Crohn s and Colitis · 3
P762 Onset of inflammatory bowel disease during treatment with secukinumab: Can anti-IL-17A be a trigger for inflammatory bowel disease?
2019 · R Rodríguez Moncada, J M Vázquez Morón, et al. · Journal of Crohn s and Colitis · 2
Factores Predictores Del Uso De Tratamientos Biológicos O Pequeñas Moléculas, Cirugías Y Hospitalizaciones En Una Cohorte De Pacientes Recién Diagnosticados De Eii: Resultados a Largo Plazo Del Estudio Epidemibd De Geteccu
2025 · Ana Garre Vázquez, Andrea Núñez Ortiz, et al. · Gastroenterología y Hepatología · 1
P1170 Long-term outcomes of newly diagnosed Inflammatory Bowel Disease (IBD) patients: results from the nationwide EpidemIBD study of GETECCU
2024 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
PDF
OP20 Risk and predictors of surgery in a newly diagnosed cohort of IBD patients in the biologic era: Results from the EpidemIBD study
2021 · M Chaparro, A Garre, et al. · Journal of Crohn s and Colitis · 1
PDF
P263 Influence of Crohn′s Disease phenotype in the retention rate of ustekinumab treatment: SUSTAIN Study
2021 · M Chaparro, I Bastón Rey, et al. · Journal of Crohn s and Colitis · 1
PDF
Pancreatobiliary maljunction: association with gallbladder cancer
2019 · Marta Garzón Benavides, Andrea Núñez Ortiz, et al. · Revista Española de Enfermedades Digestivas · 1
Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five‐Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease
2026 · Ana Garre, Andrea Nuñez Ortiz, et al. · Alimentary Pharmacology & Therapeutics
P1227 Predictors of biologics/JAKi use, surgeries, and hospitalisations in a newly diagnosed cohort of IBD patients: Long-term outcomes from the nationwide EpidemIBD study of GETECCU
2025 · A Garre, A Núñez Ortiz, et al. · Journal of Crohn s and Colitis
P755 Long-term need for restart of biologics after withdrawal in patients with Inflammatory Bowel Disease in mucosal healing
2024 · P Ruz Zafra, A M Luque Carmona, et al. · Journal of Crohn s and Colitis
PDF
DOP80 Prevalence and factors associated with Inflammatory Bowel Disease (IBD) activity during pregnancy: updated data from the DUMBO Registry
2024 · M Chaparro, M García Donday, et al. · Journal of Crohn s and Colitis
PDF
P949 Effectiveness and safety of rectal tacrolimus in patients with ulcerative colitis. TACRO-TOPIC study. A multicenter study from the young group of GETECCU
2024 · E Fuentes-Valenzuela, I Bastón-Rey, et al. · Journal of Crohn s and Colitis
PDF
Works count: 30
Citation count: 267
H-index: 7
I10-index: 5
Year
Topic
Type